|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| asco@alo33 |
161815 |
Background: The response to treatment and prognosis is poor in recurrentmetastatic head and neck squamous cell carcinoma RM HNSCC . Triple combination therapy may increase tumor response and diseas |
2.39 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161827 |
Background: The mTOR mammalian target of rapamycin inhibitor everolimus, a targeted agent used idely in cancer patients, is often discontinued due to serious adverse events. It is challenging to d |
2.4 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161830 |
Background: Microphthalmia Transcription Factor Mitf plays a central role in melanocyte maturation and differentiation, as ell as tumorigenesis. We previously proved that Mitf expression of lt 50 |
1.88 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161846 |
Background: Most patients pts ith anaplastic lymphoma kinase ALK and c-ros oncogene 1 ROS1 NSCLC develop resistance to tyrosine kinase inhibitor TKI therapy, ith the central nervous system |
2.74 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161849 |
Background: Nipple-sparing mastectomy NSM improved patientsx2019; mental and aesthetics results and shoed safe oncologic outcomes. Hoever, there ere still controversies about the indications for NS |
1.94 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161855 |
Background: The PARP inhibitorolaparib Lynparza is being evaluated in combination ith other anticancer agents. We investigated the steady-state ss PK effects and safety of olaparib tablet co-a |
2.57 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161884 |
Background: Sarcopenia, or severe skeletal muscle loss, is associated ith poor cancer outcomes including increased toxicity and reduced survival. This study investigates body composition indices inc |
2.31 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161893 |
Background: Survivorship care plans SCP are comprehensive plans that outline past, present, and future care goals for cancer survivors. As of 2015, delivery of SCP to 10 percent of eligible patien |
2.26 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161898 |
Background: In addition to its idely accepted role in cardiovascular disease, aspirin use has been associated ith decreased risk of several malignancies, especially colorectal cancer. The United Sta |
2.31 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
| asco@alo33 |
161899 |
Background: For omen ith unilateral breast cancer, a surgical option is the removal of the cancer-free breast contralateral prophylactic mastectomy, CPM . CPM among omen ith unilateral breast cance |
2.34 KB |
2023-01-16 |
|
1 |
|
|
2023-01-16
|
